Sixth JCA-AACR Special Joint Conference on the Latest Advances in Lung Cancer Research: From Basic Science to Therapeutics

July 10-12, 2018
Kyoto Tokyu Hotel
Kyoto, Japan

Organizing Committee

Hiroyuki Mano
, National Cancer Center, Tokyo, Japan
Seiji Yano, Kanazawa University, Kanazawa, Japan
Hiroyoshi Nishikawa, National Cancer Center, Tokyo, Japan

Alice T. Shaw
, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Roy S. Herbst, Yale Cancer Center, New Haven, Connecticut
Charles M. Rudin, Memorial Sloan Kettering Cancer Center, New York, New York

Topics to include:

  • Personalized treatment strategies in lung cancer
  • Latest advances in small cell lung cancer and mesothelioma
  • Targeting KRAS-mutant lung cancer
  • Overcoming resistance to targeted therapies in lung cancer
  • Novel immunotherapy strategies: Beyond PD-1/PD-L1
  • Primary and acquired mechanisms of resistance to immunotherapies
  • Tumor heterogeneity and circulating tumor DNA
  • Tumor microenvironment and implications for treatment

The JCA and AACR are proud to jointly present this Sixth JCA-AACR Special Joint Conference. This collaboration will bring together basic scientists and clinical researchers from the United States and Japan, and around the world, to share the latest and most exciting developments in lung cancer research. The conference will offer ample opportunities for the scientific discussions and interactions that are necessary to make further basic research and clinical progress in the field.